Respiratory

A promotional GSK-sponsored symposium invited three experts to discuss their main considerations when selecting an inhaled corticosteroid…

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.

Bronchiectasis is a clinical condition defined as a chronic, abnormal dilation of the bronchi accompanied by classical symptoms…

Asthma affects approximately 262 million people globally,1 with the number of asthma incidents having increased by around 15% over the…

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address health…

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes resulting in airway…

The chronic and progressive inflammatory disease bronchiectasis is characterised by permanent bronchi dilation and by symptoms such as…

The treatment landscape for potentially surgically resectable Stage IIIA non-small cell lung cancer (NSCLC), particularly for…